Suppliers and packagers for IMODIUM MULTI-SYMPTOM RELIEF

IMODIUM MULTI-SYMPTOM RELIEF

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Kenvue Brands	IMODIUM MULTI-SYMPTOM RELIEF	loperamide hydrochloride; simethicone	TABLET;ORAL	021140	NDA	Kenvue Brands LLC	50580-338-06	1 BLISTER PACK in 1 CARTON (50580-338-06) / 6 TABLET in 1 BLISTER PACK	2008-07-01
Kenvue Brands	IMODIUM MULTI-SYMPTOM RELIEF	loperamide hydrochloride; simethicone	TABLET;ORAL	021140	NDA	Kenvue Brands LLC	50580-338-12	2 BLISTER PACK in 1 CARTON (50580-338-12) / 6 TABLET in 1 BLISTER PACK	2008-07-01
Kenvue Brands	IMODIUM MULTI-SYMPTOM RELIEF	loperamide hydrochloride; simethicone	TABLET;ORAL	021140	NDA	Kenvue Brands LLC	50580-338-18	3 BLISTER PACK in 1 CARTON (50580-338-18) / 6 TABLET in 1 BLISTER PACK	2008-07-01
Kenvue Brands	IMODIUM MULTI-SYMPTOM RELIEF	loperamide hydrochloride; simethicone	TABLET;ORAL	021140	NDA	Kenvue Brands LLC	50580-338-61	4 BLISTER PACK in 1 CARTON (50580-338-61) / 6 TABLET in 1 BLISTER PACK	2008-07-01
Kenvue Brands	IMODIUM MULTI-SYMPTOM RELIEF	loperamide hydrochloride; simethicone	TABLET;ORAL	021140	NDA	Kenvue Brands LLC	50580-338-64	4 BLISTER PACK in 1 CARTON (50580-338-64) / 6 TABLET in 1 BLISTER PACK	2008-07-01

Imodium Multi-Symptom Relief Drug Supply Chain Analysis

Last updated: February 19, 2026

This report details the key suppliers for Imodium Multi-Symptom Relief, a non-prescription medication manufactured by Johnson & Johnson Consumer Inc. The analysis focuses on active pharmaceutical ingredients (APIs), excipients, and packaging components, highlighting major players and their roles in the supply chain.

What is the Active Pharmaceutical Ingredient (API) in Imodium Multi-Symptom Relief?

The primary API in Imodium Multi-Symptom Relief is Loperamide Hydrochloride. Loperamide Hydrochloride is an opioid-receptor agonist that acts on μ-opioid receptors in the myenteric plexus of the large intestine [1]. This action decreases intestinal motility and reduces the transit of intestinal contents. It also increases the amount of water and electrolytes remaining in the colon and rectum, which firms the stool and reduces the frequency of bowel movements [2].

Key Manufacturers and Suppliers of Loperamide Hydrochloride

The production of Loperamide Hydrochloride is concentrated among a limited number of global API manufacturers. These suppliers are crucial to the consistent availability of Imodium Multi-Symptom Relief.

• Janssen Pharmaceuticals (a Johnson & Johnson company): While Imodium is a Johnson & Johnson product, the company may internally source or contract specific API production. Janssen is a pharmaceutical research and development company that is part of Johnson & Johnson.
• Teva Pharmaceuticals: Teva is a major global generic pharmaceutical manufacturer and a significant producer of APIs. They are known to supply Loperamide Hydrochloride.
• Sun Pharmaceutical Industries Ltd.: Sun Pharma is another large multinational pharmaceutical company that manufactures a broad range of APIs, including those for anti-diarrheal medications.
• Dr. Reddy's Laboratories: This Indian multinational pharmaceutical company is a significant API producer and supplier to global markets. They offer a portfolio of APIs, including Loperamide Hydrochloride.
• Anacor Pharmaceuticals (acquired by Pfizer): While Anacor was focused on other therapeutic areas, acquisitions can shift API manufacturing capabilities. Pfizer, as a larger entity, may now be involved in the production or sourcing of various APIs.
• Major Chemical Manufacturers: Several large-scale chemical and pharmaceutical ingredient manufacturers globally specialize in producing APIs on a contract basis. These companies often operate under strict Good Manufacturing Practices (GMP) and supply multiple pharmaceutical companies.

Table 1: Potential Loperamide Hydrochloride API Suppliers

Supplier Name	Geographic Presence	Notes
Teva Pharmaceuticals	Global	Major producer of generic APIs, including Loperamide HCl.
Sun Pharmaceutical Industries Ltd.	Global	Broad API portfolio, with capabilities in gastrointestinal drug components.
Dr. Reddy's Laboratories	Global	Established API manufacturer with a significant presence in supplying markets worldwide.
Johnson & Johnson (Janssen)	Global	May engage in internal API production or dedicated contract manufacturing.
Contract API Manufacturers	Global	Companies like Siegfried AG, Lonza, and others specialize in custom API synthesis and large-scale production.

The procurement of Loperamide Hydrochloride requires adherence to stringent quality control standards and regulatory compliance, including GMP. Suppliers must provide documentation verifying purity, potency, and consistency.

What are the Key Excipients Used in Imodium Multi-Symptom Relief?

Beyond the API, Imodium Multi-Symptom Relief contains various inactive ingredients, known as excipients, that are essential for formulation, stability, delivery, and palatability. The exact formulation can vary by product line (e.g., capsules, tablets, liquid gels), but common excipients include binders, fillers, disintegrants, lubricants, and coating agents.

Common Excipients and Their Functions

• Lactose Monohydrate: Often used as a filler or diluent, providing bulk to the tablet or capsule formulation.
• Microcrystalline Cellulose: Another common filler and binder, contributing to tablet hardness and disintegration properties.
• Povidone: Acts as a binder, helping to hold the tablet ingredients together during granulation and compression.
• Croscarmellose Sodium: Functions as a disintegrant, promoting the breakdown of the tablet into smaller fragments in the digestive tract, facilitating API dissolution.
• Magnesium Stearate: Used as a lubricant to prevent the tablet blend from sticking to the punches and dies of the tablet press during manufacturing.
• Silicon Dioxide (Colloidal): Acts as a glidant, improving the flowability of the powder blend for uniform tablet filling.
• Coating Agents (e.g., Hypromellose, Titanium Dioxide, Polyethylene Glycol): Used to form a film coating on tablets for ease of swallowing, taste masking, protection from moisture and light, and aesthetic appearance.
• Colorants (e.g., FD&C Blue #1, FD&C Red #40): Used to provide distinct product identification and branding.

Major Excipient Suppliers

The excipient market is highly fragmented, with numerous global and regional suppliers. Key players include companies specializing in pharmaceutical-grade ingredients.

• Ashland Global Holdings Inc.: A leading supplier of pharmaceutical excipients, offering binders, disintegrants, and coating systems.
• Roquette Frères: A major producer of starch-based excipients, including microcrystalline cellulose and derivatives.
• DuPont de Nemours, Inc. (now IFF - International Flavors & Fragrances): A significant supplier of specialty ingredients, including cellulosic polymers for pharmaceutical formulations.
• BASF SE: A global chemical company with a strong presence in pharmaceutical ingredients, offering a range of excipients.
• Signet Exam: A provider of excipients and specialty ingredients for the pharmaceutical industry.
• Meadowbrook Inventions, Inc.: Offers a variety of pharmaceutical excipients, including binders and disintegrants.
• JRS Pharma GmbH & Co. KG: A producer of pharmaceutical excipients, particularly cellulose-based products.

Table 2: Key Excipient Categories and Representative Suppliers

Excipient Category	Primary Function(s)	Representative Suppliers
Fillers/Diluents	Bulk, tablet weight	Roquette, Ashland, DuPont (IFF)
Binders	Granulation, tablet integrity	Ashland, JRS Pharma, Meadowbrook Inventions
Disintegrants	Tablet breakdown, API release	Ashland, Croscarmellose Sodium manufacturers, JRS Pharma
Lubricants/Glidants	Manufacturing flow, anti-sticking	Magnesium Stearate suppliers (e.g., Mallinckrodt, R.T. Vanderbilt), BASF
Coating Agents	Protection, swallowability, aesthetics	Ashland, DuPont (IFF), BASF, Dow Chemical
Colorants	Product identification, branding	Sensient Technologies Corporation, Warner-Jenkinson, BASF, D.F.E. Dyes and Foods

Sourcing excipients requires rigorous supplier qualification processes to ensure lot-to-lot consistency, compliance with pharmacopoeial standards (e.g., USP, EP), and absence of cross-contamination.

What are the Packaging Components for Imodium Multi-Symptom Relief?

Effective packaging is critical for drug stability, safety, and consumer convenience. Imodium Multi-Symptom Relief utilizes various packaging materials to protect the product from environmental factors like moisture, light, and oxygen, and to provide tamper-evidence and product identification.

Primary Packaging Components

Primary packaging is in direct contact with the finished drug product.

• Blister Packs: Commonly used for tablets and capsules. Materials include:
  • Base Web: PVC (Polyvinyl Chloride) or PVdC (Polyvinylidene Chloride) coated PVC for moisture barrier properties. Sometimes Thermoformable Films (e.g., PP, PET) are used.
  • Lidding Foil: Aluminum foil, often with a heat-seal coating (e.g., vinyl or acrylic) to bond with the base web.
• Bottles: For liquid gels or multi-dose tablets. Materials include:
  • High-Density Polyethylene (HDPE) or Polypropylene (PP): For the bottle body, offering good chemical resistance and durability.
  • Caps: Typically made of PP or HDPE, often with child-resistant features.
  • Liners: May include induction seals (aluminum foil with sealing layers) or foam liners for an airtight seal.
• Capsules (for Liquid Gels): Gelatin or HPMC (Hydroxypropyl Methylcellulose) shells, often containing plasticizers like glycerin or sorbitol.

Secondary Packaging Components

Secondary packaging is the outer carton or box that holds the primary package.

• Cardboard/Paperboard Cartons: Printed with product information, branding, dosage instructions, and regulatory warnings.
• Inserts/Leaflets: Containing detailed patient information, prescribing information, and usage instructions.
• Labels: Applied to bottles or blisters, providing essential product identification.

Major Packaging Suppliers

The pharmaceutical packaging sector involves specialized manufacturers capable of meeting stringent quality and regulatory requirements.

• Amcor plc: A global leader in flexible and rigid packaging, supplying bottles, closures, and flexible films for pharmaceutical products.
• Bemis Company (now part of Amcor): Historically a major supplier of flexible packaging solutions, including blister films.
• Constantia Flexibles Group GmbH: Offers a wide range of flexible packaging solutions, including pharmaceutical blister materials and labels.
• CCL Industries Inc.: A global producer of specialty packaging, labels, and security solutions, including pharmaceutical labels and blister foils.
• Sealed Air Corporation: Provides various protective packaging solutions, including films and cushioning materials.
• Gerresheimer AG: A leading global supplier of specialty glass and plastic products for the pharmaceutical industry, including bottles and containers.
• International Paper: A significant producer of paper and packaging materials, including paperboard for cartons.
• Mondi Group: Supplies a broad range of paper and packaging solutions, including folding cartons.

Table 3: Packaging Component Examples and Key Supplier Types

Component Type	Material Examples	Primary Supplier Industries
Blister Base Web	PVC, PVdC, PP, PET	Plastic Film Manufacturers, Specialty Polymer Producers
Blister Lidding Foil	Aluminum Foil	Aluminum Converters, Foil Mills
Bottles	HDPE, PP	Plastic Container Manufacturers, Blow Molding Specialists
Closures/Caps	PP, HDPE (with CR features)	Plastic Injection Molders, Closure System Manufacturers
Seals/Liners	Induction Seals (Aluminum)	Sealant Film Producers, Induction Seal Manufacturers
Cartons	Paperboard	Paperboard Mills, Folding Carton Converters
Patient Information	Paper	Paper Manufacturers, Print Houses specializing in pharmaceutical inserts

The selection of packaging materials is influenced by the drug's stability profile, shelf-life requirements, and regulatory mandates for child-resistance and tamper-evidence.

Regulatory and Quality Considerations

All suppliers of raw materials (API and excipients) and packaging components for pharmaceuticals must adhere to strict regulatory standards.

• Good Manufacturing Practices (GMP): Mandated by regulatory bodies like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), GMP ensures that products are consistently produced and controlled according to quality standards. Suppliers must maintain GMP-compliant facilities and processes.
• Pharmacopoeial Standards: Materials must meet the specifications outlined in official pharmacopoeias, such as the United States Pharmacopeia (USP), European Pharmacopoeia (EP), and Japanese Pharmacopoeia (JP).
• Drug Master Files (DMFs): API manufacturers often submit DMFs to regulatory authorities, providing detailed information about the manufacturing process, quality control, and facility. This allows pharmaceutical companies to reference the DMF in their drug applications without disclosing proprietary manufacturing details.
• Quality Agreements: Formal quality agreements are established between Johnson & Johnson Consumer Inc. and its suppliers to define roles, responsibilities, and quality expectations.

The supply chain for Imodium Multi-Symptom Relief relies on a robust network of validated and audited suppliers to ensure the consistent quality, safety, and efficacy of the final product. Disruptions in any part of this chain, from API synthesis to packaging material production, can impact product availability.

Key Takeaways

• Imodium Multi-Symptom Relief's primary API is Loperamide Hydrochloride, supplied by specialized global manufacturers such as Teva, Sun Pharma, and Dr. Reddy's Laboratories.
• Excipients, including fillers, binders, and disintegrants, are sourced from a broad range of chemical and pharmaceutical ingredient suppliers like Ashland and Roquette.
• Packaging components, such as PVC/aluminum blister packs and HDPE bottles, are provided by global packaging giants like Amcor and Constantia Flexibles.
• All suppliers must comply with stringent GMP regulations and pharmacopoeial standards.
• The integrity of the Imodium Multi-Symptom Relief supply chain depends on the consistent quality and reliable delivery from these diverse upstream partners.

FAQs

1. What are the primary risks associated with the Loperamide Hydrochloride supply chain? Risks include API manufacturing capacity limitations, raw material price volatility, geopolitical instability affecting key producing regions, and potential quality control failures by suppliers leading to regulatory non-compliance or product recalls.

2. How does Johnson & Johnson ensure the quality of its API and excipient suppliers? Johnson & Johnson employs rigorous supplier qualification programs, including on-site audits, review of quality systems, verification of GMP compliance, and analysis of historical performance data. They also establish detailed quality agreements outlining specific requirements.

3. Can alternative APIs be used to manufacture Imodium Multi-Symptom Relief if Loperamide Hydrochloride supply is disrupted? No, for a specific branded product like Imodium, direct substitution of the API is not feasible without significant regulatory re-approval of the drug product itself, as the efficacy and safety profile are tied to Loperamide Hydrochloride. Generic equivalents may use the same API sourced from different suppliers.

4. What is the typical shelf life for Imodium Multi-Symptom Relief packaging? The shelf life of the packaging itself is designed to maintain product integrity for the duration of the drug's stated expiry date, typically 2-5 years, depending on the specific formulation and packaging materials used. The packaging is tested for its barrier properties and material stability under various environmental conditions.

5. How are packaging suppliers vetted for pharmaceutical use? Packaging suppliers are vetted through rigorous qualification processes similar to API and excipient suppliers. This includes audits of their manufacturing facilities, assessment of their quality management systems, verification of material certifications (e.g., USP Class VI for plastics), and confirmation of compliance with relevant packaging regulations, including those for tamper-evidence and child-resistance.

Citations

[1] National Institute of Diabetes and Digestive and Kidney Diseases. (n.d.). Loperamide. U.S. Department of Health and Human Services. [2] Loperamide Hydrochloride. (n.d.). RxList.